📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. (2021)

First Author: Roddie C
Attributed to:  Large scale lentiviral vector production funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1200/jco.21.00917

PubMed Identifier: 34464155

Publication URI: http://europepmc.org/abstract/MED/34464155

Type: Journal Article/Review

Volume: 39

Parent Publication: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Issue: 30

ISSN: 0732-183X